Home Overview Press Room Blog Publications For Students about us
Search

Patents & Other IP : Displaying 208-217 of 344


House Panel Discusses International Limits On Gene Study to Prevent Competitive Abuse[Quotes CGS's Richard Hayes]The Bureau of National AffairsJune 21st, 2008An international consensus on this research and its application must be achieved, panelists told a House subcommittee on terrorism.
Letting Sleeping Dogs Lieby Jesse ReynoldsBiopolitical TimesJune 12th, 2008The leadership of the California stem cell research agency has commissioned a new economic report. Any realistic economic analysis may not be an effective shield in Sacramento during a period of drastic budget cuts, and by reviving past controversy, revisiting the economic argument may backfire.
Dog Cloning and Intellectual Propertyby Marcy Darnovsky and Jesse ReynoldsBiopolitical TimesJune 5th, 2008In the minor flurry of stories last month about an on-line auction of dog cloning services, the issue of intellectual property was completely overlooked. That’s too bad, since the cloning business, like so many others, is best understood by following the money.
Unseen Rise of ‘Body Shopping’by Donna DickensonThe Sunday TimesApril 20th, 2008Good science can’t be rushed, and the commercialisation of biotechnology needs proper examination. The problem is that parliament is too busy arguing about God to pay much attention.
Another Bill to Reform the California Stem Cell Research Programby Jesse ReynoldsBiopolitical TimesMarch 4th, 2008For the fourth year in a row, the Democratic chair of the California Senate Health Committee, currently Sheila Kuehl, and her Republican colleague, George Runner, have introduced a bill to address some of the flaws in the California stem cell research program.
Elimination of conflicts of interest at stem cell institute target of billby Terri SomersSan Diego Union TribuneFebruary 23rd, 2008A bipartisan bill introduced in the state Senate yesterday would authorize California's Little Hoover Commission to investigate how the state stem cell institute's governance structure might be changed to eliminate inherent conflicts of interest.
Are male eggs and female sperm on the horizon?[Quotes CGS's Marcy Darnovsky]by Peter AldhousNew ScientistFebruary 2nd, 2008In a handful of labs across the world, biologists are trying to make genetically male cells develop into eggs, and female cells into sperm.
Stem-cell Firms Resisting Cash LureInstitute Offers Grants with Strings Attachedby Steve JohnsonSan Jose Mercury NewsDecember 20th, 2007Although companies now have a chance for the first time in the institute's three-year history to apply for its money, they may wind up having to share some of their revenue and research. And that is giving some companies second thoughts about participating.
ICOC OKs For-Profit IP, Revenue Policies Amid Probes of Alleged Conflict of Interest[Quotes CGS's Jesse Reynolds]by Joyce E. CutlerThe Bureau of National AffairsDecember 14th, 2007California's stem cell agency approved regulations covering intellectual property and revenue sharing requirements for commercial enterprises accepting state stem cell research money.
WARF and Thomson Go for Patents with New Stem Cell Developmentsby Jesse ReynoldsBiopolitical TimesNovember 20th, 2007The leader of one of the two teams behind today's big stem cell developments plans on filing a patent on the technique.
Displaying 208-217 of 344  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760